CryoPort (NASDAQ:CYRX) Announces Earnings Results

CryoPort (NASDAQ:CYRX) released its quarterly earnings data on Thursday. The consumer goods maker reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.02, reports. CryoPort had a negative net margin of 35.71% and a negative return on equity of 17.32%. The company had revenue of $9.58 million during the quarter, compared to analyst estimates of $9.49 million. During the same quarter in the prior year, the business earned ($0.07) earnings per share. The business’s quarterly revenue was up 81.1% compared to the same quarter last year.

Shares of CryoPort stock traded down $0.25 during trading hours on Friday, hitting $14.03. The company’s stock had a trading volume of 762,100 shares, compared to its average volume of 379,665. The company has a market capitalization of $526.06 million, a PE ratio of -45.26 and a beta of 0.77. The business has a fifty day moving average of $15.05 and a 200 day moving average of $17.84. CryoPort has a 1-year low of $8.28 and a 1-year high of $25.02. The company has a quick ratio of 17.68, a current ratio of 17.73 and a debt-to-equity ratio of 0.17.

Several equities research analysts have recently issued reports on the stock. Svb Leerink reissued an “outperform” rating on shares of CryoPort in a research report on Monday, July 15th. BidaskClub lowered shares of CryoPort from a “sell” rating to a “strong sell” rating in a research report on Saturday, October 5th. B. Riley set a $26.00 price objective on shares of CryoPort and gave the stock a “buy” rating in a research report on Friday, July 19th. Leerink Swann assumed coverage on shares of CryoPort in a research report on Monday, July 15th. They issued a “buy” rating and a $24.00 price objective for the company. Finally, ValuEngine raised shares of CryoPort from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. One analyst has rated the stock with a sell rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $24.00.

CryoPort Company Profile

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.

Recommended Story: What is the outlook for the FAANG stocks?

Earnings History for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with's FREE daily email newsletter.

Leave a Reply